cannabigérol

Cannabigerol, often abbreviated as CBG, is a cannabinoid found in the cannabis plant. It is present in relatively small amounts, typically less than 1% in most strains, though some specialized strains are bred to have higher concentrations. CBG is sometimes referred to as the "mother cannabinoid" because it is the precursor to other cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD).

As the cannabis plant matures, enzymes convert CBG into other cannabinoids. This means that immature plants will contain higher levels of CBG compared to mature ones. CBG is non-intoxicating, meaning it does not produce the psychoactive effects associated with THC.

Research into CBG is ongoing, and its potential therapeutic properties are being investigated. Early studies suggest it may have anti-inflammatory, antibacterial, and neuroprotective effects. However, much of the research is still in its preliminary stages, with many studies conducted on cell cultures or animal models rather than humans.

Due to its low natural abundance, extracting significant amounts of CBG can be challenging and costly. As research progresses and demand grows, there is increasing interest in developing efficient extraction methods and cultivating cannabis strains with elevated CBG content. The legal status of CBG generally follows that of other cannabis-derived compounds, varying by jurisdiction.